Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Gill

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
The New England Journal of Medicine|January 13, 1983
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentratesJ E Menitove, R H Aster, J T Casper, et al.
British Journal of Haematology|September 1, 1996
Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study GroupsD Menache, D L Aronson, F Darr, et al.
Transfusion|May 1, 1983
Prepooled cryoprecipitate for treatment of hemophilia AJ E Menitove, J A Spero, W A Richards, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 5, 2016
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection SystemR Kulkarni, R J Presley, J M Lusher, et al.
Thrombosis and Haemostasis|December 30, 1998
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitorsN S Key, L M Aledort, D Beardsley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 20, 2016
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia AR Klamroth, M Simpson, M von Depka-Prondzinski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2011
Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment CentresV R Byams, P A Kouides, R Kulkarni, et al.
Proceedings. Biological Sciences|October 30, 2015
Geographical variation in species' population responses to changes in temperature and precipitationJames W Pearce-Higgins, Nancy Ockendon, David J Baker, et al.
Thrombosis and Haemostasis|June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II studyC Leissinger, C D Josephson, S Granger, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
The New England Journal of Medicine|January 13, 1983
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentratesJ E Menitove, R H Aster, J T Casper, et al.
British Journal of Haematology|September 1, 1996
Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study GroupsD Menache, D L Aronson, F Darr, et al.
Transfusion|May 1, 1983
Prepooled cryoprecipitate for treatment of hemophilia AJ E Menitove, J A Spero, W A Richards, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 5, 2016
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection SystemR Kulkarni, R J Presley, J M Lusher, et al.
Thrombosis and Haemostasis|December 30, 1998
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitorsN S Key, L M Aledort, D Beardsley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 20, 2016
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia AR Klamroth, M Simpson, M von Depka-Prondzinski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2011
Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment CentresV R Byams, P A Kouides, R Kulkarni, et al.
Proceedings. Biological Sciences|October 30, 2015
Geographical variation in species' population responses to changes in temperature and precipitationJames W Pearce-Higgins, Nancy Ockendon, David J Baker, et al.
Thrombosis and Haemostasis|June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II studyC Leissinger, C D Josephson, S Granger, et al.
Pageof 8